Aurora Cannabis is a Canadian licensed cannabis producer that has eight production facilities and five sales licenses in Canada. The company is headquartered in Edmonton, Alberta, and trades on the Toronto Stock Exchange (TSX) and the Nasdaq stock market (Nasdaq: ACB).
Organigram
Aurora Cannabis is a Canadian medical cannabis company. The Company primarily operates in Canada and plans to expand to the United States. It has facilities in Canada and more than 20 other countries. Currently, it has 190 employees.
Aurora Cannabis was formed in 2013 and is a cannabis upstart. It is a Licensed Producer in Canada. In addition, it has facilities in Australia, Germany, the Netherlands, and the U.S. There are several brands of the company, including Bevo, Being, Greybeard, and San Rafael ’71.
The Company started generating revenues from its medical cannabis products in January 2016. For the first time, Aurora is offering same-day delivery to patients in Edmonton and Calgary. It also has a mobile app that enables patients to order the product. This app uses encryption to protect patient privacy.
Aurora is executing a comprehensive plan to gain market share in Canada. It expects to become a leading global player in the marijuana industry. However, it still has work to do to secure its future.
Hempco
Aurora Cannabis announced its acquisition of Hempco Food and Fiber Inc. (TSXV: HFC) on March 13, 2019. The deal is valued at C$63.4 million, and Aurora will pay C$1.04 for each Hempco share.
Hempco Food and Fiber is a hemp-based food products manufacturer. It produces nutritional supplements, fiber, and hemp-derived consumer products.
Hempco is a vertically-integrated company, with a full-service food production facility in Nisku, Alberta, Canada. Through its two brands, Planet Hemp and Praise, Hempco offers a variety of hemp-based derivative products. These include hemp-based protein powder, hemp-based food, and fiber.
Aurora’s acquisition of the remaining interest in Hempco will allow it to strengthen its market position in the hemp-derived CBD market. Aurora will be able to accelerate the growth of its premium hemp-based product offerings and research into cultivation yield enhancements.
The transaction is expected to close in the second quarter of 2019 and will require approval by two-thirds of the Hempco Shareholders. Hempco’s Board of Directors has recommended to shareholders that they vote in favor of the Transaction.
Radient Cannabis
Radient Technologies is an international cannabinoid-based formulations manufacturer. The company has a proprietary extraction technology that can recover up to 99% of active compounds from the cannabis plant. This extraction process is based on continuous-flow methods and has proven to be highly effective.
Radient is developing a portfolio of cannabis extracts for a variety of uses. These cannabinoid-based products include CBD, terpenes, and THC. They are manufactured in a variety of forms. In addition, the company has announced plans to develop a new line of premium vape extracts and distillate dabs.
As part of its strategy, Radient plans to invest in its product lines and supply chain. It has been developing a number of partnerships, including with the cosmetics and pharmaceutical industries. Aside from its existing cannabinoid extraction facilities in Canada, the company has also invested in a facility in Germany.
Currently, the company has a CAD $25.0 million cannabis biomass inventory. It is expected to process the majority of this inventory over the next two fiscal quarters.
